AI Article Synopsis
- * Key improvements observed included less protein-losing enteropathy, decreased intestinal bleeding, and better weight gain in the patient.
- * While sirolimus showed promise in managing JPS symptoms and reducing the frequency of medical evaluations, it does not fully replace the need for surgical polyp removal.
Article Abstract
In the following clinical case of infantile juvenile polyposis syndrome (JPS), administration of a pharmacologic agent sirolimus was associated with reduced disease burden without need for bowel resection. The positive impact included improvement in protein-losing enteropathy, decreased intestinal blood loss, and improved weight gain. In addition, the number of polyps resected per unit time and frequency of upper and lower endoscopic evaluation needed dropped after initiation of sirolimus. This case report describes a positive clinical outcome and discusses the use of sirolimus with aggressive polypectomy as a potential treatment for the rare disease entity of polygenic infantile JPS. Through this case, we aim to emphasize that while administration of this drug may mitigate many sequelae of infantile JPS, it does not appear to eliminate the need for aggressive polypectomy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8913018 | PMC |
| http://dx.doi.org/10.14740/gr1480 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the effect of polygenic background on epilepsy phenotype in 'monogenic' families.
EBioMedicine
November 2024
Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia; Department of Medical Biology, The University of Melbourne, Parkville, VIC, Australia. Electronic address:
Article Synopsis
- The study investigated how polygenic risk factors influence the severity and occurrence of epilepsy within families that have a known genetic cause, particularly focusing on families with genetic epilepsy with febrile seizures plus (GEFS+).
- Researchers analyzed data from 304 individuals, finding that a higher polygenic risk score (PRS) was linked to a greater likelihood of an epilepsy diagnosis and was associated with more severe epilepsy phenotypes.
- The results suggest that the genetic background can modify how rare pathogenic variants express themselves in terms of disease severity, highlighting the role of polygenic risk in understanding familial epilepsy.
Testing for pharmacogenomic predictors of ppRNFL thinning in individuals exposed to vigabatrin.
Front Neurosci
September 2023
School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
Background: The anti-seizure medication vigabatrin (VGB) is effective for controlling seizures, especially infantile spasms. However, use is limited by VGB-associated visual field loss (VAVFL). The mechanisms by which VGB causes VAVFL remains unknown.
View Article and Find Full Text PDFMachine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab.
Clin Pharmacol Ther
September 2023
Experimental and Clinical Pharmacology Unit, Centro di Riferimento Oncologico di Aviano, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Italy.
Pharmacogenomics studies how genes influence a person's response to treatment. When complex phenotypes are influenced by multiple genetic variations with little effect, a single piece of genetic information is often insufficient to explain this variability. The application of machine learning (ML) in pharmacogenomics holds great potential - namely, it can be used to unravel complicated genetic relationships that could explain response to therapy.
View Article and Find Full Text PDFGenotype and phenotype characteristics of West syndrome in 20 Vietnamese children: Two novel variants detected by next-generation sequencing.
Epilepsy Res
February 2023
Neurology Department, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City 70000, Vietnam; Neurology Department, Children Hospital 2, Ho Chi Minh City 70000, Vietnam. Electronic address:
Background: In children with West syndrome (WS), whose treatment is challenging due to drug resistance and poor prognosis, investigation of genetic etiology and genotype-phenotype characteristics might assist in treatment optimization and genetic counseling.
Objective: In this study, we aimed to present the results of genetic analysis and the corresponding phenotypes in a cohort of twenty children with WS in Vietnam.
Methods: Our study was designed as a single-institution retrospective case series, in which consecutive sampling was used to select WS children having undergone genetic testing.
Common risk variants for epilepsy are enriched in families previously targeted for rare monogenic variant discovery.
EBioMedicine
July 2022
Department of Medicine, Epilepsy Research Centre, University of Melbourne, Austin Health, 245 Burgundy St, Heidelberg, VIC 3084, Australia. Electronic address:
Background: The epilepsies are highly heritable conditions that commonly follow complex inheritance. While monogenic causes have been identified in rare familial epilepsies, most familial epilepsies remain unsolved. We aimed to determine (1) whether common genetic variation contributes to familial epilepsy risk, and (2) whether that genetic risk is enriched in familial compared with non-familial (sporadic) epilepsies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!